Reference is made to previous announcement on January 11, 2022, concerning the
issuing of consideration shares in connection with the acquisition of Medrave
The share capital increase pertaining to the placement is now registered with
the Norwegian Register of Business Enterprises ("Foretaksregisteret"). The new
share capital of the Company is NOK 105,554,537.136 divided into 79,245,148
shares at NOK 1.332 per share.